• EI
  • Scopus
  • 食品科学与工程领域高质量科技期刊分级目录第一方阵T1
  • DOAJ
  • EBSCO
  • 北大核心期刊
  • 中国核心学术期刊RCCSE
  • JST China
  • FSTA
  • 中国精品科技期刊
  • 中国农业核心期刊
  • CA
  • WJCI
  • 中国科技核心期刊CSTPCD
  • 中国生物医学SinoMed
中国精品科技期刊2020
郭均, 黄燕燕, 刘冬梅, 孙丽娜, 冯立科, 杨爱君, 彭小霞, 吴晖, 李理. 植物乳杆菌DMDL 9010制剂调控SD大鼠脂质水平的研究[J]. 食品工业科技, 2018, 39(8): 285-290. DOI: 10.13386/j.issn1002-0306.2018.08.052
引用本文: 郭均, 黄燕燕, 刘冬梅, 孙丽娜, 冯立科, 杨爱君, 彭小霞, 吴晖, 李理. 植物乳杆菌DMDL 9010制剂调控SD大鼠脂质水平的研究[J]. 食品工业科技, 2018, 39(8): 285-290. DOI: 10.13386/j.issn1002-0306.2018.08.052
GUO Jun, HUANG Yan-yan, LIU Dong-mei, SUN Li-na, FENG Li-ke, YANG Ai-jun, PENG Xiao-xia, WU Hui, LI Li. Regulation of Lactobacillus plantarum DMDL 9010 preparation on lipids level of rats[J]. Science and Technology of Food Industry, 2018, 39(8): 285-290. DOI: 10.13386/j.issn1002-0306.2018.08.052
Citation: GUO Jun, HUANG Yan-yan, LIU Dong-mei, SUN Li-na, FENG Li-ke, YANG Ai-jun, PENG Xiao-xia, WU Hui, LI Li. Regulation of Lactobacillus plantarum DMDL 9010 preparation on lipids level of rats[J]. Science and Technology of Food Industry, 2018, 39(8): 285-290. DOI: 10.13386/j.issn1002-0306.2018.08.052

植物乳杆菌DMDL 9010制剂调控SD大鼠脂质水平的研究

Regulation of Lactobacillus plantarum DMDL 9010 preparation on lipids level of rats

  • 摘要: 探讨植物乳杆菌DMDL 9010(Lactobacillus plantarum DMDL 9010)对SD大鼠脂质水平的影响。以无菌水、1 mg/mL阿托伐他汀水溶液、高剂量(109 CFU/mL)和低剂量(107 CFU/mL)L. plantarum DMDL 9010菌悬液连续灌胃SD大鼠10周,监测大鼠体重和血清、肝脏、粪便的脂质水平变化。结果显示:高剂量(109 CFU/mL)L.plantarum DMDL 9010能显著降低大鼠血清总胆固醇(TC)(23.03%)、低密度脂蛋白(28.00%)和动脉硬化指数(34.04%)(p<0.05),显著降低大鼠肝脏TC(33.20%)和甘油三酯(TG)(40.86%)(p<0.05),增加粪便TC(31.07%)和胆汁酸(TBA)(70.18%)排泄(p<0.05),肝脏病理切片观察表明,L. plantarum DMDL 9010能改善肝细胞脂肪变性。得出L. plantarum DMDL 9010以剂量依赖的方式降低血清和肝脏的TC和TG,提高粪便TC和TBA排泄,从而有效调控其脂质水平,为开发预防和治疗高胆固醇血症的益生菌制剂提供了可能。

     

    Abstract: The effects of Lactobacillus plantarum DM10 9010 on lipid levels were studied. SD rats fed with high fat diet were randomly divided into normal group,model group,positive group and experimental group.The rats were treated with sterile water,1 mg/mL aqueous solution of atorvastatin calcium,high dose(109 CFU/mL)and low dose(107 CFU/mL)L. plantarum DMDL 9010 suspension for 10 weeks to measure the level changes of body weight,blood lipid level(total cholesterol(TC),triglyceride(TG),high density lipoprotein cholesterol(HDL-C)and low density lipoprotein cholesterol(LDL-C)),liver lipid level(TC,TG,pathological sections)and fecal lipid(cholesterol,total bile acid(TBA)). The results showed that high dose of L. plantarum DMDL 9010 could significantly decrease serum total cholesterol(23.03%),low density lipoprotein cholesterol(28.00%)and arteriosclerosis index(34.04%)(p<0.05)in hyperlipidemic rats. Liver morphology and pathological section observation showed that L. plantarum DMDL9010 could improve liver cell steatosis. In addition,high-dose L. plantarum DMDL9010(109 CFU/mL)significantly reduced TC(33.20%)and TG(40.86%)(p<0.05)in the liver of high-fat rats,and increased fecal TC(31.07%)and TBA(70.18%)(p<0.05). To sum up,it showed that L. plantarum DMDL 9010 might be effective in inhibiting the accumulation of cholesterol by increas the amount of TC and TBA in the feces. Liver pathology showed that L. plantarum DMDL9010 could improve hepatic steatosis.L. plantarum DMDL 9010 could reduce TC and TG in serum and liver in a dose-dependent manner,increase the excretion of TC and TBA in the feces,thereby effectively regulate its lipid levels and provide a probiotic preparation for the prevention and treatment of hypercholesterolemia.

     

/

返回文章
返回